Ronald Joseph Gurrera, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroleptic Malignant Syndrome | 14 | 2017 | 74 | 3.360 |
Why?
|
| Clozapine | 4 | 2022 | 504 | 1.610 |
Why?
|
| Mental Competency | 6 | 2013 | 178 | 1.160 |
Why?
|
| Antipsychotic Agents | 9 | 2022 | 3064 | 1.110 |
Why?
|
| Pneumonia, Aspiration | 2 | 2018 | 145 | 1.060 |
Why?
|
| Informed Consent | 6 | 2013 | 1008 | 0.840 |
Why?
|
| Hyponatremia | 2 | 2019 | 280 | 0.770 |
Why?
|
| Schizophrenic Psychology | 8 | 2014 | 1645 | 0.680 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2019 | 87 | 0.640 |
Why?
|
| Personality Disorders | 4 | 2014 | 719 | 0.610 |
Why?
|
| Personality | 5 | 2005 | 553 | 0.550 |
Why?
|
| Neutropenia | 1 | 2022 | 885 | 0.550 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2017 | 62 | 0.540 |
Why?
|
| Myocarditis | 2 | 2022 | 792 | 0.480 |
Why?
|
| Schizotypal Personality Disorder | 2 | 2006 | 289 | 0.470 |
Why?
|
| Serotonin Syndrome | 1 | 2013 | 18 | 0.450 |
Why?
|
| Trazodone | 1 | 2013 | 67 | 0.450 |
Why?
|
| Tramadol | 1 | 2013 | 60 | 0.430 |
Why?
|
| Schizophrenia | 12 | 2016 | 6930 | 0.420 |
Why?
|
| Oxycodone | 1 | 2013 | 139 | 0.400 |
Why?
|
| Bupropion | 1 | 2013 | 304 | 0.390 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2017 | 1990 | 0.380 |
Why?
|
| Neuropsychological Tests | 9 | 2014 | 7046 | 0.370 |
Why?
|
| Professional Competence | 1 | 2014 | 430 | 0.370 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2013 | 489 | 0.360 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2005 | 531 | 0.340 |
Why?
|
| Personality Inventory | 8 | 2014 | 1018 | 0.340 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 2021 | 0.340 |
Why?
|
| Consensus | 2 | 2017 | 3134 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2270 | 0.320 |
Why?
|
| Dementia | 6 | 2017 | 2684 | 0.320 |
Why?
|
| Cognition | 4 | 2014 | 6988 | 0.310 |
Why?
|
| Sympathetic Nervous System | 4 | 2007 | 519 | 0.300 |
Why?
|
| Decision Making | 6 | 2010 | 3931 | 0.290 |
Why?
|
| Veterans | 2 | 2021 | 2654 | 0.290 |
Why?
|
| Creatine Kinase | 3 | 2006 | 684 | 0.280 |
Why?
|
| Adrenal Medulla | 2 | 1999 | 56 | 0.270 |
Why?
|
| Sodium Chloride | 1 | 2007 | 584 | 0.240 |
Why?
|
| Leadership | 1 | 2014 | 1385 | 0.240 |
Why?
|
| Temporal Lobe | 3 | 2007 | 1695 | 0.240 |
Why?
|
| Cognition Disorders | 3 | 2007 | 3976 | 0.220 |
Why?
|
| Malignant Hyperthermia | 1 | 2002 | 72 | 0.200 |
Why?
|
| Iron | 2 | 2006 | 1790 | 0.200 |
Why?
|
| Psychiatry | 1 | 2014 | 1699 | 0.200 |
Why?
|
| Psychometrics | 5 | 2007 | 3061 | 0.190 |
Why?
|
| Mental Disorders | 2 | 2021 | 6823 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2008 | 2787 | 0.180 |
Why?
|
| Curriculum | 1 | 2014 | 3741 | 0.180 |
Why?
|
| Body Temperature Regulation | 3 | 1999 | 292 | 0.180 |
Why?
|
| Frontal Lobe | 1 | 2006 | 1416 | 0.170 |
Why?
|
| Residential Treatment | 1 | 2021 | 111 | 0.170 |
Why?
|
| Foster Home Care | 1 | 2021 | 133 | 0.170 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2021 | 928 | 0.170 |
Why?
|
| Antidiuretic Agents | 1 | 2019 | 21 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2014 | 6011 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1725 | 0.160 |
Why?
|
| Humans | 49 | 2022 | 761208 | 0.150 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2018 | 103 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 3805 | 0.140 |
Why?
|
| Seizures | 2 | 2022 | 2965 | 0.140 |
Why?
|
| Water Intoxication | 1 | 1996 | 10 | 0.140 |
Why?
|
| Male | 33 | 2019 | 360693 | 0.140 |
Why?
|
| Norepinephrine | 1 | 1999 | 897 | 0.130 |
Why?
|
| Comprehension | 3 | 2007 | 619 | 0.130 |
Why?
|
| Hallucinations | 1 | 2018 | 366 | 0.130 |
Why?
|
| Neural Pathways | 1 | 2006 | 3056 | 0.130 |
Why?
|
| Epinephrine | 1 | 1999 | 791 | 0.120 |
Why?
|
| Off-Label Use | 1 | 2017 | 185 | 0.120 |
Why?
|
| Problem Solving | 2 | 2010 | 443 | 0.120 |
Why?
|
| Drug Interactions | 1 | 2019 | 1417 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2014 | 5885 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7400 | 0.110 |
Why?
|
| Age of Onset | 2 | 2017 | 3307 | 0.110 |
Why?
|
| Factor Analysis, Statistical | 3 | 2005 | 998 | 0.110 |
Why?
|
| Vanilmandelic Acid | 1 | 1992 | 17 | 0.110 |
Why?
|
| Choice Behavior | 3 | 2010 | 825 | 0.100 |
Why?
|
| Enzymes | 1 | 1993 | 252 | 0.100 |
Why?
|
| Health Status | 1 | 2005 | 4077 | 0.100 |
Why?
|
| Catecholamines | 1 | 1992 | 387 | 0.090 |
Why?
|
| Psychotic Disorders | 1 | 2006 | 3220 | 0.090 |
Why?
|
| Interdisciplinary Studies | 1 | 2011 | 86 | 0.090 |
Why?
|
| Fever | 1 | 2018 | 1618 | 0.090 |
Why?
|
| Accreditation | 1 | 2014 | 473 | 0.090 |
Why?
|
| Female | 22 | 2019 | 392544 | 0.090 |
Why?
|
| Arousal | 2 | 1996 | 1171 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2014 | 763 | 0.090 |
Why?
|
| Personality Assessment | 3 | 2005 | 649 | 0.080 |
Why?
|
| Memory | 4 | 2008 | 2190 | 0.080 |
Why?
|
| Adult | 17 | 2018 | 221119 | 0.070 |
Why?
|
| Delphi Technique | 1 | 2011 | 848 | 0.070 |
Why?
|
| Personal Autonomy | 1 | 2010 | 306 | 0.070 |
Why?
|
| Hyperhidrosis | 1 | 2007 | 34 | 0.070 |
Why?
|
| Models, Psychological | 2 | 1993 | 830 | 0.070 |
Why?
|
| Fornix, Brain | 1 | 2007 | 71 | 0.070 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2007 | 109 | 0.070 |
Why?
|
| Middle Aged | 16 | 2019 | 220853 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2640 | 0.070 |
Why?
|
| Severity of Illness Index | 6 | 2007 | 15841 | 0.070 |
Why?
|
| Adrenal Gland Diseases | 1 | 2007 | 141 | 0.070 |
Why?
|
| Language Tests | 1 | 2006 | 190 | 0.060 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 77 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 8603 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 623 | 0.060 |
Why?
|
| Empirical Research | 1 | 2005 | 120 | 0.060 |
Why?
|
| Haloperidol | 1 | 2006 | 390 | 0.060 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2007 | 268 | 0.060 |
Why?
|
| Executive Function | 1 | 2013 | 1388 | 0.060 |
Why?
|
| Ambulatory Care | 3 | 2010 | 2770 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2014 | 6345 | 0.060 |
Why?
|
| Aged | 14 | 2017 | 169288 | 0.060 |
Why?
|
| Verbal Learning | 1 | 2006 | 463 | 0.060 |
Why?
|
| Telephone | 1 | 2007 | 624 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 7966 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2006 | 2359 | 0.050 |
Why?
|
| Memory Disorders | 2 | 2007 | 1198 | 0.050 |
Why?
|
| Monoamine Oxidase | 2 | 1995 | 182 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2000 | 1791 | 0.050 |
Why?
|
| Hypothalamus | 2 | 1999 | 999 | 0.050 |
Why?
|
| Data Collection | 1 | 2011 | 3320 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14675 | 0.050 |
Why?
|
| Sex Factors | 3 | 2005 | 10553 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 951 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2014 | 8642 | 0.050 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 26071 | 0.050 |
Why?
|
| Patient Participation | 2 | 2010 | 1445 | 0.040 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2001 | 147 | 0.040 |
Why?
|
| Observer Variation | 1 | 2007 | 2610 | 0.040 |
Why?
|
| Attitude | 1 | 2005 | 771 | 0.040 |
Why?
|
| Age Factors | 1 | 2017 | 18384 | 0.040 |
Why?
|
| Intelligence | 1 | 2004 | 922 | 0.040 |
Why?
|
| Adolescent | 6 | 2019 | 88298 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2017 | 4575 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 59221 | 0.040 |
Why?
|
| Axons | 1 | 2006 | 1671 | 0.040 |
Why?
|
| Educational Status | 1 | 2006 | 2510 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 12976 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2005 | 6242 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 1401 | 0.040 |
Why?
|
| United States | 3 | 2021 | 72339 | 0.030 |
Why?
|
| Thermoreceptors | 1 | 1996 | 27 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2007 | 58952 | 0.030 |
Why?
|
| Depression | 2 | 1995 | 8132 | 0.030 |
Why?
|
| Thermosensing | 1 | 1996 | 55 | 0.030 |
Why?
|
| Brain | 2 | 2001 | 27092 | 0.030 |
Why?
|
| Attention | 1 | 2006 | 2394 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 659 | 0.030 |
Why?
|
| Body Surface Area | 1 | 1996 | 197 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6223 | 0.030 |
Why?
|
| Functional Laterality | 3 | 2007 | 2257 | 0.030 |
Why?
|
| Dehydration | 1 | 1996 | 216 | 0.030 |
Why?
|
| Hospitalization | 2 | 2014 | 10707 | 0.030 |
Why?
|
| Hippocampus | 1 | 2007 | 3754 | 0.030 |
Why?
|
| Models, Biological | 1 | 1990 | 9457 | 0.030 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1993 | 43 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1838 | 0.030 |
Why?
|
| Metanephrine | 1 | 1992 | 25 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1993 | 410 | 0.030 |
Why?
|
| Blood Platelets | 2 | 1995 | 2477 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 1993 | 411 | 0.020 |
Why?
|
| Affective Symptoms | 1 | 1995 | 417 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80674 | 0.020 |
Why?
|
| Alcoholism | 2 | 1993 | 1973 | 0.020 |
Why?
|
| Mass Screening | 1 | 2007 | 5426 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1999 | 1769 | 0.020 |
Why?
|
| Child | 1 | 2019 | 80152 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1993 | 859 | 0.020 |
Why?
|
| Psychoanalytic Theory | 1 | 1990 | 138 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15308 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 64681 | 0.020 |
Why?
|
| Chronic Disease | 4 | 2007 | 9319 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 74239 | 0.020 |
Why?
|
| Muscles | 1 | 1993 | 1568 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20119 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 21365 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1999 | 4165 | 0.020 |
Why?
|
| Homeostasis | 1 | 1999 | 3320 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2008 | 503 | 0.020 |
Why?
|
| Thinking | 1 | 2010 | 319 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2007 | 257 | 0.020 |
Why?
|
| Probability | 1 | 1992 | 2478 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 12052 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1992 | 1528 | 0.010 |
Why?
|
| Anisotropy | 1 | 2008 | 1284 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1990 | 1047 | 0.010 |
Why?
|
| Prosopagnosia | 1 | 2005 | 64 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1999 | 4487 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1437 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36415 | 0.010 |
Why?
|
| Longevity | 1 | 2010 | 1063 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1992 | 2691 | 0.010 |
Why?
|
| Outpatients | 1 | 2010 | 1598 | 0.010 |
Why?
|
| Social Perception | 1 | 2005 | 431 | 0.010 |
Why?
|
| Face | 1 | 2007 | 1025 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1221 | 0.010 |
Why?
|
| Comorbidity | 1 | 1995 | 10516 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Visual Perception | 1 | 2008 | 1385 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1486 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2006 | 22174 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1992 | 8479 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1993 | 4413 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7804 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2005 | 1716 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 168079 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2004 | 6635 | 0.010 |
Why?
|
| Quality of Life | 1 | 2010 | 13367 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4921 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 29687 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39126 | 0.000 |
Why?
|
| Emotions | 1 | 1995 | 2742 | 0.000 |
Why?
|